Abstract
Gold complexes have a long tradition in medicine and for many examples antirheumatic,
anticancer or anti-infective effects have been confirmed. Here we evaluated the lead
compound Auranofin and five selected gold organometallics as inhibitors of two relevant drug
targets of severe acute respiratory syndrome coronaviruses (SARS-CoV). The gold
metallodrugs were effective inhibitors of the interaction of the SARS-CoV-2 spike protein with
the angiotensin converting enzyme 2 (ACE2) host receptor and might thus interfere with the
viral entry process. The gold metallodrugs were also efficient inhibitors of the SARS-CoV-1
papain-like protease (PLpro), which is a key enzyme in the viral replication. Taken together,
the results of this pilot study suggest further evaluation of gold complexes as SARS-CoV
antiviral drugs.